Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Trends in Mortality in People With HIV From 1999 through 2020: A Multicohort Collaboration.

Autor: Tusch E; Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Ryom L; Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Department of Infectious Diseases, Hvidovre University Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Pelchen-Matthews A; Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London, United Kingdom., Mocroft A; Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London, United Kingdom., Elbirt D; Allergy, Immunology and HIV Unit, Kaplan Medical Center, Rehovot, Israel., Oprea C; HIV department, Victor Babes Clinical Hospital for Infectious and Tropical Diseases, Bucharest, Romania., Günthard HF; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Staehelin C; Department of Infectious Diseases, Bern University Hospital, University of Bern, Bern, Switzerland., Zangerle R; Austrian HIV Cohort Study (AHIVCOS), Medizinische Universität Innsbruck, Innsbruck, Austria., Suarez I; Department I for Internal Medicine, University Hospital Cologne, Cologne, Germany., Vehreschild JJ; Department I for Internal Medicine, University Hospital Cologne, Cologne, Germany., Wit F; AIDS Therapy Evaluation in the Netherlands (ATHENA) Cohort, HIV Monitoring Foundation, Amsterdam, The Netherlands., Menozzi M; Modena HIV Cohort, Università degli Studi di Modena, Modena, Italy., d'Arminio Monforte A; Italian Cohort Naive Antiretrovirals (ICONA), ASST Santi Paolo e Carlo, Milano, Italy., Spagnuolo V; Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milano, Italy., Pradier C; Nice HIV Cohort, Université Côte d'Azur et Centre Hospitalier Universitaire, Nice, France., Carlander C; Swedish InfCare HIV Cohort, Karolinska University Hospital, Stockholm, Sweden., Suanzes P; Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain., Wasmuth JC; Infectious Diseases/HIV Department of the Medical Clinic I, University Hospital Bonn, Bonn, Germany., Carr A; HIV and Immunology Unit, St Vincent's Hospital, Sydney, New South Wales, Australia., Petoumenos K; Australian HIV Observational Database (AHOD), UNSW, Sydney, New South Wales, Australia., Borgans F; Department of Internal Medicine, Infectious Diseases, Frankfurt HIV Cohort Study, Goethe-University Hospital, University Hospital, Frankfurt, Germany., Bonnet F; Bordeaux Population Health Centre & CHU de Bordeaux, University of Bordeaux, National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Saint-André Hospital, Service de Médecine Interne et Maladies Infectieuses, Bordeaux, Cedex, France., De Wit S; Department of Infectious Diseases, St Pierre University Hospital, Brussels, Belgium., El-Sadr W; Mailman School of Public Health, Columbia University, New York, New York, USA., Neesgaard B; Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Jaschinski N; Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Greenberg L; Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Hosein SR; European AIDS Treatment Group (EATG), Brussels, Belgium., Gallant J; Gilead Sciences, Foster City, California, USA., Vannappagari V; ViiV Healthcare, Research Triangle Park, North Carolina, USA., Young L; Merck Sharp & Dohme, Rahway, New Jersey, USA., Sabin C; Centre for Clinical Research, Epidemiology, Modelling and Evaluation, Institute for Global Health, University College London, London, United Kingdom., Lundgren J; Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Peters L; Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Reekie J; Centre of Excellence for Health, Immunity and Infections (CHIP), Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Nov 22; Vol. 79 (5), pp. 1242-1257.

Clinical characteristics of women with HIV in the RESPOND cohort: A descriptive analysis and comparison to men.

Autor: Hutchinson J; The Australian HIV Observational Database (AHOD), The Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia., Neesgard B; CHIP, Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Kowalska J; Medical University of Warsaw, Warsaw, Poland., Grabmeier-Pfistershammer K; Austrian HIV Cohort Study (AHIVCOS), Department Of Dermatology, Medical University of Vienna, Vienna, Austria., Johnson M; Department of Infectious Diseases and Hospital Epidemiology, Royal Free London NHS Foundation Trust, London, UK., Kusejko K; University Hospital Zurich; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., De Wit S; Saint-Pierre University Hospital, Infectious Diseases Department, Université Libre de Bruxelles, Brussels, Belgium., Wit F; AIDS Therapy Evaluation in the Netherlands (ATHENA) Cohort, HIV Monitoring Foundation, Amsterdam, the Netherlands.; Division of Infectious Diseases, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands., Mussini C; Modena HIV Cohort, Università degli Studi di Modena, Modena, Italy.; Italian Cohort Naive Antiretrovirals (ICONA), Milan, Italy., Castagna A; San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milan, Italy., Stecher M; University Hospital Cologne, Cologne, Germany., Pradier C; Nice HIV Cohort, Université Côte d'Azur et Centre Hospitalier Universitaire, Nice, France., Domingo P; Sant Pau and Santa Creu Hospital, Barcelona, Spain., Carlander C; Swedish InfCareHIV, Karolinska University Hospital, Solna, Sweden., Wasmuth J; University Hospital Bonn, Bonn, Germany., Chkhartishvili N; Georgian National AIDS Health Information System (AIDS HIS), Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia., Uzdaviniene V; Vilnius University Hospital Santaros Klinikos, Vilnius, Lithuania., Haberl A; Medical Center, Infectious Diseases Unit, Goethe-University Hospital, Frankfurt, Germany., d'Arminio Monforte A; Italian Cohort Naive Antiretrovirals (ICONA), Milan, Italy., Garges H; ViiV Healthcare, RTP, Research Triangle Park, North Carolina, USA., Gallant J; Gilead Sciences, Foster City, California, USA., Said M; European AIDS Treatment Group (EATG), Division of Infectious Diseases, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands., Schmied B; Austrian HIV Cohort Study (AHIVCOS), Department Of Dermatology, Medical University of Vienna, Vienna, Austria., van der Valk M; AIDS Therapy Evaluation in the Netherlands (ATHENA) Cohort, HIV Monitoring Foundation, Amsterdam, the Netherlands.; Division of Infectious Diseases, Amsterdam Infection and Immunity Institute, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands., Konopnicki D; Saint-Pierre University Hospital, Infectious Diseases Department, Université Libre de Bruxelles, Brussels, Belgium., Jaschinski N; CHIP, Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Mocroft A; CHIP, Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Institute for Global Health, University College London, London, UK., Greenberg L; CHIP, Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark., Burns F; Department of Infectious Diseases and Hospital Epidemiology, Royal Free London NHS Foundation Trust, London, UK.; Institute for Global Health, University College London, London, UK., Ryom L; CHIP, Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Department of Infectious Disease 144, Hvidovre University Hospital, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark., Petoumenos K; The Australian HIV Observational Database (AHOD), The Kirby Institute, UNSW Sydney, Sydney, New South Wales, Australia.

Publikováno v: HIV medicine [HIV Med] 2024 Sep; Vol. 25 (9), pp. 1058-1074. Date of Electronic Publication: 2024 Jun 05.